Vaccines Market 2025 - 2035

Reports - Vaccines Market

Healthcare

Vaccines Market

Vaccines Market Valuation and Growth Forecast 2025-2035 by Technology (excluding COVID 19 vaccines) (Conjugate vaccines, Inactivated & Subunit vaccines, Live Attenuated vaccines, Recombinant vaccines, Toxoid vaccines, Viral vector vaccines) by Technology (including COVID 19 vaccines) (mRNA vaccines, Viral Vector vaccines, Others) by Type (Monovalent vaccines, Multivalent vaccines) by Disease Indication (Influenza, Pneumococcal diseases, Combination vaccines, HPV, Herpes Zoster, Meningococcal diseases, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, COVID 19, Others) by Route of Administration (Intramuscular & Subcutaneous administration, Oral administration, Others) by End-user (Pediatric vaccines, Adult vaccines) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Request Sample Access TOC

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insight View Inclusion

Chapter 1 Executive Dashboard

1. Strategic Imperatives

Chapter 2 Premium Insights

1. Top 3 Trends to Watch

2. Demand and Supply Trends

3. Top 3 Strategies Followed by Major Players

4. Top 3 Predictions by Vantage Market Research

5. Top Investment Pockets

6. Insights from Primary Respondents

Chapter 3 Global Vaccines Market - Segment Analysis

1. Overview

2. Global Vaccines Market, 2021 - 2035 (USD Million)

3. Global Vaccines Market - by Technology (excluding COVID 19 vaccines)

3.1. By Conjugate vaccines

3.2. By Inactivated & Subunit vaccines

3.3. By Live Attenuated vaccines

3.4. By Recombinant vaccines

3.5. By Toxoid vaccines

3.6. By Viral vector vaccines

4. Global Vaccines Market - by Technology (including COVID 19 vaccines)

4.1. By mRNA vaccines

4.2. By Viral Vector vaccines

4.3. By Others

5. Global Vaccines Market - by Type

5.1. By Monovalent vaccines

5.2. By Multivalent vaccines

6. Global Vaccines Market - by Disease Indication

6.1. By Influenza

6.2. By Pneumococcal diseases

6.3. By Combination vaccines

6.4. By HPV

6.5. By Herpes Zoster

6.6. By Meningococcal diseases

6.7. By Rotavirus

6.8. By MMR

6.9. By Varicella

6.10. By Hepatitis

6.11. By DTP

6.12. By Polio

6.13. By COVID 19

6.14. By Others

7. Global Vaccines Market - by Route of Administration

7.1. By Intramuscular & Subcutaneous administration

7.2. By Oral administration

7.3. By Others

8. Global Vaccines Market - by End-user

8.1. By Pediatric vaccines

8.2. By Adult vaccines

9. Global Vaccines Market - by region

9.1. North America

9.2. Europe

9.3. Asia Pacific

9.4. Latin America

9.5. Middle East & Africa

10. Market comparative analysis

Chapter 4 North America Vaccines Market - Segment Analysis

1. Overview

2. North America Vaccines Market, 2021 - 2035 (USD Million)

3. North America Vaccines Market - by Technology (excluding COVID 19 vaccines)

3.1. By Conjugate vaccines

3.2. By Inactivated & Subunit vaccines

3.3. By Live Attenuated vaccines

3.4. By Recombinant vaccines

3.5. By Toxoid vaccines

3.6. By Viral vector vaccines

4. North America Vaccines Market - by Technology (including COVID 19 vaccines)

4.1. By mRNA vaccines

4.2. By Viral Vector vaccines

4.3. By Others

5. North America Vaccines Market - by Type

5.1. By Monovalent vaccines

5.2. By Multivalent vaccines

6. North America Vaccines Market - by Disease Indication

6.1. By Influenza

6.2. By Pneumococcal diseases

6.3. By Combination vaccines

6.4. By HPV

6.5. By Herpes Zoster

6.6. By Meningococcal diseases

6.7. By Rotavirus

6.8. By MMR

6.9. By Varicella

6.10. By Hepatitis

6.11. By DTP

6.12. By Polio

6.13. By COVID 19

6.14. By Others

7. North America Vaccines Market - by Route of Administration

7.1. By Intramuscular & Subcutaneous administration

7.2. By Oral administration

7.3. By Others

8. North America Vaccines Market - by End-user

8.1. By Pediatric vaccines

8.2. By Adult vaccines

Chapter 5 Europe Vaccines Market - Segment Analysis

1. Overview

2. Europe Vaccines Market, 2021 - 2035 (USD Million)

3. Europe Vaccines Market - by Technology (excluding COVID 19 vaccines)

3.1. By Conjugate vaccines

3.2. By Inactivated & Subunit vaccines

3.3. By Live Attenuated vaccines

3.4. By Recombinant vaccines

3.5. By Toxoid vaccines

3.6. By Viral vector vaccines

4. Europe Vaccines Market - by Technology (including COVID 19 vaccines)

4.1. By mRNA vaccines

4.2. By Viral Vector vaccines

4.3. By Others

5. Europe Vaccines Market - by Type

5.1. By Monovalent vaccines

5.2. By Multivalent vaccines

6. Europe Vaccines Market - by Disease Indication

6.1. By Influenza

6.2. By Pneumococcal diseases

6.3. By Combination vaccines

6.4. By HPV

6.5. By Herpes Zoster

6.6. By Meningococcal diseases

6.7. By Rotavirus

6.8. By MMR

6.9. By Varicella

6.10. By Hepatitis

6.11. By DTP

6.12. By Polio

6.13. By COVID 19

6.14. By Others

7. Europe Vaccines Market - by Route of Administration

7.1. By Intramuscular & Subcutaneous administration

7.2. By Oral administration

7.3. By Others

8. Europe Vaccines Market - by End-user

8.1. By Pediatric vaccines

8.2. By Adult vaccines

Chapter 6 Asia Pacific Vaccines Market - Segment Analysis

1. Overview

2. Asia Pacific Vaccines Market, 2021 - 2035 (USD Million)

3. Asia Pacific Vaccines Market - by Technology (excluding COVID 19 vaccines)

3.1. By Conjugate vaccines

3.2. By Inactivated & Subunit vaccines

3.3. By Live Attenuated vaccines

3.4. By Recombinant vaccines

3.5. By Toxoid vaccines

3.6. By Viral vector vaccines

4. Asia Pacific Vaccines Market - by Technology (including COVID 19 vaccines)

4.1. By mRNA vaccines

4.2. By Viral Vector vaccines

4.3. By Others

5. Asia Pacific Vaccines Market - by Type

5.1. By Monovalent vaccines

5.2. By Multivalent vaccines

6. Asia Pacific Vaccines Market - by Disease Indication

6.1. By Influenza

6.2. By Pneumococcal diseases

6.3. By Combination vaccines

6.4. By HPV

6.5. By Herpes Zoster

6.6. By Meningococcal diseases

6.7. By Rotavirus

6.8. By MMR

6.9. By Varicella

6.10. By Hepatitis

6.11. By DTP

6.12. By Polio

6.13. By COVID 19

6.14. By Others

7. Asia Pacific Vaccines Market - by Route of Administration

7.1. By Intramuscular & Subcutaneous administration

7.2. By Oral administration

7.3. By Others

8. Asia Pacific Vaccines Market - by End-user

8.1. By Pediatric vaccines

8.2. By Adult vaccines

Chapter 7 Latin America Vaccines Market - Segment Analysis

1. Overview

2. Latin America Vaccines Market, 2021 - 2035 (USD Million)

3. Latin America Vaccines Market - by Technology (excluding COVID 19 vaccines)

3.1. By Conjugate vaccines

3.2. By Inactivated & Subunit vaccines

3.3. By Live Attenuated vaccines

3.4. By Recombinant vaccines

3.5. By Toxoid vaccines

3.6. By Viral vector vaccines

4. Latin America Vaccines Market - by Technology (including COVID 19 vaccines)

4.1. By mRNA vaccines

4.2. By Viral Vector vaccines

4.3. By Others

5. Latin America Vaccines Market - by Type

5.1. By Monovalent vaccines

5.2. By Multivalent vaccines

6. Latin America Vaccines Market - by Disease Indication

6.1. By Influenza

6.2. By Pneumococcal diseases

6.3. By Combination vaccines

6.4. By HPV

6.5. By Herpes Zoster

6.6. By Meningococcal diseases

6.7. By Rotavirus

6.8. By MMR

6.9. By Varicella

6.10. By Hepatitis

6.11. By DTP

6.12. By Polio

6.13. By COVID 19

6.14. By Others

7. Latin America Vaccines Market - by Route of Administration

7.1. By Intramuscular & Subcutaneous administration

7.2. By Oral administration

7.3. By Others

8. Latin America Vaccines Market - by End-user

8.1. By Pediatric vaccines

8.2. By Adult vaccines

Chapter 8 Middle East & Africa Vaccines Market - Segment Analysis

1. Overview

2. Middle East & Africa Vaccines Market, 2021 - 2035 (USD Million)

3. Middle East & Africa Vaccines Market - by Technology (excluding COVID 19 vaccines)

3.1. By Conjugate vaccines

3.2. By Inactivated & Subunit vaccines

3.3. By Live Attenuated vaccines

3.4. By Recombinant vaccines

3.5. By Toxoid vaccines

3.6. By Viral vector vaccines

4. Middle East & Africa Vaccines Market - by Technology (including COVID 19 vaccines)

4.1. By mRNA vaccines

4.2. By Viral Vector vaccines

4.3. By Others

5. Middle East & Africa Vaccines Market - by Type

5.1. By Monovalent vaccines

5.2. By Multivalent vaccines

6. Middle East & Africa Vaccines Market - by Disease Indication

6.1. By Influenza

6.2. By Pneumococcal diseases

6.3. By Combination vaccines

6.4. By HPV

6.5. By Herpes Zoster

6.6. By Meningococcal diseases

6.7. By Rotavirus

6.8. By MMR

6.9. By Varicella

6.10. By Hepatitis

6.11. By DTP

6.12. By Polio

6.13. By COVID 19

6.14. By Others

7. Middle East & Africa Vaccines Market - by Route of Administration

7.1. By Intramuscular & Subcutaneous administration

7.2. By Oral administration

7.3. By Others

8. Middle East & Africa Vaccines Market - by End-user

8.1. By Pediatric vaccines

8.2. By Adult vaccines

Chapter 9 Key Market Dynamics

1. Introduction

2. Market Drivers

3. Market Restraints

4. Market Opportunities

5. Porter's Five Forces Analysis

6. PEST Analysis

7. Regulatory Landscape

8. Technology Landscape

9. Regional Market Trends

Chapter 10 COVID 19 Impact Analysis

1. Key strategies undertaken by companies to tackle COVID-19

2. Short term dynamics

3. Long term dynamics

Chapter 11 Marketing Strategy Analysis

1. Marketing Channel

2. Direct Marketing

3. Indirect Marketing

4. Marketing Channel Development Trends

Chapter 12 Competitive Landscape

1. Competition Matrix - 2021

2. Company Market Share Analysis - 2021

3. Key Company Activities, 2018 - 2021

4. Strategic Developments - Heat Map Analysis

5. Company Offering Evaluation

6. Company Regional Presence Evaluation

Chapter 13 Company Profiles

1. GlaxoSmithKline plc (UK)

2. Merck & Co. Inc. (US)

3. Pfizer Inc. (US)

4. Sanofi SA (France)

5. CSL Limited (Australia)

6. Emergent BioSolutions Inc. (US)

7. Johnson & Johnson (US)

8. AstraZeneca plc (UK)

9. Serum Institute of India Pvt. Ltd. (India)

10. Bavarian Nordic A/S (Denmark)

11. Mitsubishi Tanabe Pharma Corporation (Japan)

12. Daiichi Sankyo Company

13. Limited (Japan)

14. Panacea Biotec Ltd. (India)

15. Biological E Limited (India)

16. Bharat Biotech Ltd. (India)

17. Novavax Inc. (US)

18. FSUE NPO Microgen (Russia)

19. Sinovac Biotech Ltd. (China)

20. Incepta Vaccine Limited (Bangladesh)

21. Valneva SE (France)

22. VBI Vaccines (US)

23. PT Bio Farma (Persero) (Indonesia)

24. Inovio Pharmaceuticals Inc. (US)

25. Chongqing Zhifei Biological Products Co. Ltd. (China)

26. Indian Immunologicals Limited (India).

Chapter 14 Key Primary Respondents - VERBATIM

Chapter 15 Discussion Guide

Chapter 16 Customization Offered

Chapter 17 Annexure

Chapter 18 List of Figures

Chapter 19 List of Tables

Chapter 20 List of Abbreviations

Customize your report

Cross-Segment Market Size And Analysis For Mentioned Segments

Additional Company Profiles (Upto 5 With No Cost)

Additional Countries (Apart From Mentioned Countries)

Country/Region-Specific Report

Go To Market Strategy

Region Specific Market Dynamics

Region Level Market Share

Import Export Analysis

Others

FAQ‘s

Related Reports

Healthcare

Canine Vaccines Market

Ganesh Palve

16 Oct 2024

5 Min Read

Canine Vaccines Market Size, Share & Trends Analysis Report by Types (Canine Distemper, Canine Parvovirus, Tracheobronchitis, Canine Coronavirus, Canine Leptospirosis)...

From $ 4999

Healthcare

Seasonal Influenza Vaccines Therapeutics Market

Mrudula Shah

16 Oct 2024

5 Min Read

Seasonal Influenza Vaccines Therapeutics Market Size, Share & Trends Analysis Report by Types (Paediatrics, Adolescence, Adults, Elderly) by Application (Hospitals,...

From $ 4999

Healthcare

Animal Vaccines Market

Mrudula Shah

25 Jul 2024

5 Min Read

Animal Vaccines Market Size, Share & Trends Analysis Report by Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines,...

From $ 4999

Healthcare

Meningococcal Vaccines Market

Mrudula Shah

29 May 2024

5 Min Read

Meningococcal Vaccines Market Size, Share & Trends Analysis Report by Type (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines) by Age Group...

From $ 4999

Healthcare

Therapeutic Vaccines Market

Ganesh Palve

15 Jan 2024

5 Min Read

Therapeutic Vaccines Market Size, Share & Trends Analysis Report by Product (Addiction Vaccines, Autoimmune Disease Vaccines, Neurological Disease Vaccines, Infectious...

From $ 4999

Vaccines Market

Vaccines Market Size, Share & Trends Analysis Report by Technology (excluding COVID 19 vaccines) (Conjugate vaccines, Inactivated & Subunit vaccines,...

From $ 4999

Company

About Us Services Contact Us Career

Quicklinks

How to order All reports Latest reports Upcoming reports Press Release Blogs

Support

Contact

US Office:

224 W 35th St Ste 500, New York, NY 10001, United States

India Office:

Kamdhenu Jasmine, Main Road, Pimple Saudagar, Pune, Maharashtra, 411027

+1 (212) 951-1369

Toll Free Number+1 (877) 462-2282

sales@vantagemarketresearch.com

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

Secured By

Vaccines Market

Table of Contents

Customize your report

FAQ‘s

Related Reports